Roivant Sciences Ltd.(ROIV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ROIV Roivant Sciences Ltd.

Pre-Mkt 09-23 06:21:29 EDT

38.22

-0.77

-1.97%

盘前38.72

+0.50+1.31%

05:04 EDT

High39.17	Low38.11	Vol6.75M
Open38.73	D1 Closing38.99	Amplitude2.72%
Mkt Cap27.61B	Tradable Cap22.21B	Total Shares722.41M
T/O259.35M	T/O Rate1.16%	Tradable Shares581.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ROIV","market":"US","secType":"STK","nameCN":"Roivant Sciences Ltd.","latestPrice":38.22,"timestamp":1790107200000,"preClose":38.99,"halted":0,"volume":6752726,"hourTrading":{"tag":"盘前","latestPrice":38.72,"preClose":38.22,"latestTime":"05:04 EDT","volume":2,"amount":78.5076,"timestamp":1790154289972,"change":0.5,"changeRate":0.013082,"amplitude":0.027933},"delay":0,"changeRate":-0.019748653500897745,"floatShares":581000000,"shares":722406273,"eps":-0.47,"marketStatus":"Pre-Mkt","change":-0.77,"latestTime":"09-23 06:21:29 EDT","open":38.73,"high":39.17,"low":38.11,"amount":259353993.557978,"amplitude":0.027186,"askPrice":43.63,"askSize":100,"bidPrice":38.62,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.47,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790170200000},"marketStatusCode":1,"adr":0,"listingDate":1607403600000,"exchange":"NASDAQ","adjPreClose":38.22,"preHourTrading":{"tag":"盘前","latestPrice":38.72,"preClose":38.22,"latestTime":"05:04 EDT","volume":2,"amount":78.5076,"timestamp":1790154289972,"change":0.5,"changeRate":0.013082,"amplitude":0.027933},"postHourTrading":{"tag":"盘后","latestPrice":38.37,"preClose":38.22,"latestTime":"19:46 EDT","volume":729248,"amount":27872992.2375,"timestamp":1790120808938,"change":0.15,"changeRate":0.003925,"amplitude":0.004448},"volumeRatio":0.5654504834965258,"impliedVol":0.3945,"impliedVolPercentile":0.456},"requestUrl":"/m/hq/s/ROIV/","defaultTab":"news","newsList":[{"id":"2668928863","title":"Roivant Sciences Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2668928863","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668928863?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:15","pubTimestamp":1789730117,"startTime":"0","endTime":"0","summary":"Roivant Sciences holds annual shareholder meetingRoivant Sciences held its annual general meeting on Sept. 16, 2026.Shareholders backed the reappointment of Ernst & Young LLP as independent auditor fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL5J39Jd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4007","BK4139","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990118","title":"Roivant Sciences Director Meghan FitzGerald Reports $203,159 Common Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990118","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990118?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:42","pubTimestamp":1789684974,"startTime":"0","endTime":"0","summary":"Roivant Sciences director Meghan FitzGerald reports $203,159 common share saleDirector Meghan FitzGerald sold 5,112 Roivant Sciences common shares on Sep. 15, 2026.Sales priced at USD 39.68 per share ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL2fxFl6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Roivant Sciences Director Meghan FitzGerald Reports $203,159 Common Share Sale","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ROIV","PTH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961223","title":"Stifel Nicolaus Initiates Roivant Sciences With Buy Rating, $51 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961223","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961223?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:40","pubTimestamp":1789645253,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus Initiates Roivant Sciences With Buy Rating, $51 Price Target","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTH","ROIV","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668782966","title":"Roivant Sciences Ltd : Stifel Initiates Coverage with Buy Rating; Target Price $51","url":"https://stock-news.laohu8.com/highlight/detail?id=2668782966","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668782966?lang=en_us&edition=fundamental","pubTime":"2026-09-17 18:45","pubTimestamp":1789641905,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ROIV","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668966903","title":"Roivant Sciences Price Target Announced at $51.00/Share by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2668966903","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668966903?lang=en_us&edition=fundamental","pubTime":"2026-09-17 18:34","pubTimestamp":1789641240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ROIV/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","BK4139","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993375","title":"Roivant Sciences initiated with a Buy at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993375","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993375?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:15","pubTimestamp":1789589720,"startTime":"0","endTime":"0","summary":"Stifel initiated coverage of Roivant Sciences (ROIV) with a Buy rating and $51 price target The company offers a “compelling multi-asset story with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FLSP","ROIV","TBFC","BAMO","TCTL","LEXI","PLGI","USAF","AOR","RULE","PTH","GDMA","MDAA","QIS","BK4007","ASGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667649179","title":"Roivant Sciences Ltd : Leerink Partners Raises Target Price to $52 from $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2667649179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667649179?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:55","pubTimestamp":1789469735,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN45707O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4139","PTH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667466962","title":"Bellevue Flags US Healthcare Innovation as Driving Fresh Investment Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2667466962","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667466962?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:11","pubTimestamp":1789391469,"startTime":"0","endTime":"0","summary":"Bellevue flags US healthcare innovation as driving fresh investment opportunitiesBellevue Group AG flagged patient-outcome innovation as a key driver of healthcare investment opportunities from recent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL8lm3Sh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTH","LU0985320562.USD","LU0006061336.USD","BK4082","LU0072461881.USD","LU0266013472.USD","LU0878866978.SGD","LU1571399168.USD","LU1854104046.USD","LU1894683264.USD","IE00BFXG1179.USD","LU1201861165.SGD","LU0511384066.AUD","BK4007","UTHR","LU0433182093.SGD","LU0289961442.SGD","BK4532","LU1894683348.USD","BK4504","LU1854103824.USD","LU1059921491.USD","LU1150488218.USD","LU0162691827.USD","IHI","LU0130103400.USD","LU1150488135.SGD","LU0648000940.SGD","BK4588","LU0068578508.USD","ROIV","LU0289739343.SGD","BK4585","LU0477156797.USD","BDX","LU0985489474.SGD","LU1699723380.USD","LU0130518102.USD","LU1489326972.SGD","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666512383","title":"Roivant Sciences Director Meghan FitzGerald Disposes of USD 798,000 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666512383","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666512383?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:01","pubTimestamp":1789088474,"startTime":"0","endTime":"0","summary":"Roivant Sciences director Meghan FitzGerald disposes of USD 798,000 in common sharesRoivant director Meghan FitzGerald exercised stock options for 20,000 common shares at USD 8.8 on Sept. 8.She sold 2","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL33g4Z7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Roivant Sciences Director Meghan FitzGerald Disposes of USD 798,000 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4007","BK4139","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666041535","title":"Roivant Sciences Price Target Raised to $46.00/Share from $42.00 by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2666041535","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666041535?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:30","pubTimestamp":1788960600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ROIV/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ROIV","BK4007","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374542","title":"U.S. Stocks on the MOVE-Best Buy, Peloton, Apple","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374542","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374542?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:36","pubTimestamp":1788889011,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Best Buy, Peloton, AppleSeptember 8 (Reuters)-The major U.S. stock indexes edged lower on Tuesday as fresh hostilities in the Middle East pushed oil prices higher, while m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL6N4500HU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COHH","NATO","DFTX","AAPU","ILMN","ROM","AMGN","LITE","AMD","SMHX","EFSI","INTC","PHVS","SINTCmain","DYN","QCOM","RGTI","AAPL","BHVN","IONQ","SEI","MTB","UNFI","SRPT","ROIV","TTXU","PJP","RPRX","CQTM","QCMD","SPTE","QNT","COHR","ABM","SHAK","HWM","COHX","NTLA","IONX","BE","SAAPLmain","BSX","INFQ","QBTS","DAMD","MACW.SI","P","ALV","IONS","CHRW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666637458","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666637458","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666637458?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:27","pubTimestamp":1788888467,"startTime":"0","endTime":"0","summary":"Roivant Sciences  shares soared 19% after the company said its Pulmovant unit's phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease, or PH-ILD, met its primary and secondary endpoints.More than 13.5 million shares of the company traded intraday compared with a daily average of about 6.26 million.Intel  is expected to raise personal computer central processing unit prices by another 10% in early October, Digitimes reported, citing supply chain sources.Shares jumped 10%, with intraday trading volume at over 86.0 million, versus the stock's daily average of about 113.4 million.Pharvaris  said that a global phase 3 study of deucrictibant extended-release tablets met the primary endpoint of reducing the mean monthly attack rate by 83%, compared with placebo, in people with hereditary angioedema.Wedbush Securities adjusted Pharvaris' price target to $50 from $42 while maintaining its outperform rating.Shares climbed 10% as int","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE000WAW04H5.SGD","AIQ","IE0000B7K699.USD","LU2360106780.USD","LU0321505439.SGD","LU2357627491.SGD","QQQA","LU0097036916.USD","LU0719512351.SGD","LU0149725797.USD","LU2089985449.USD","LU2244417387.USD","XNTK","BK4554","SOXX","LINT","BK4533","LU2764263039.SGD","BK4535","LU0187121727.USD","BK4529","IE000F7OJYX1.SGD","LEGR","IE000BZT7R73.USD","IE000SO60NU8.SGD","BK4585","AIS","BK4575","BK4543","LU2543165471.USD","04335","LU0154236417.USD","BK4612","LU2250418816.HKD","INYY","DRIV","LU0859254822.USD","BK4550","ROIV","BK4527","BK4139","BK4605","LU0274383776.USD","HK0000304805.HKD","LU0082616367.USD","INT","BK4579","PHVS","BK4602","IE000MB6IJN5.SGD","LU0251131958.USD","SINTCmain","BK4534","CHPS","LU1852331112.SGD","BK4141","HK0000304797.USD","LU2931357623.SGD","TTEQ","BK4512","LU0081259029.USD","LU2720916845.USD","BK4007","LU0251142724.SGD","LU2764263203.CNY","INTW","LU0048573561.USD","LU2764262908.HKD","LU0742534661.SGD","BK4515","LU0056508442.USD","FTXL","PTH","LU0321505868.SGD","BK4588","IE000M9KFDE8.USD","INTC","LU2148611432.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666492371","title":"Roivant Sciences price target raised to $47 from $41 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2666492371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666492371?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:35","pubTimestamp":1788885318,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Roivant Sciences (ROIV) to $47 from $41 and keeps a Buy rating on the shares. The firm believes m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-47-from-41-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-47-from-41-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ROIV","BK4007","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376643","title":"Roivant Sciences rises 17.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376643?lang=en_us&edition=fundamental","pubTime":"2026-09-08 22:05","pubTimestamp":1788876358,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) is up 17.6%, or $6.15 to $41.08. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-rises-17-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-rises-17-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ROIV","BK4007","BK4139","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665752763","title":"U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2665752763","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665752763?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:57","pubTimestamp":1788875845,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, NovartisSeptember 8 (Reuters)-Wall Street's main indexes were mixed at open on Tuesday as fresh hostilities in the Middle East pushed oil price","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL6N4500HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0238689110.USD","IONL","LU1153585028.USD","LU0154245673.USD","LU2506952097.USD","IONZ","LU1064131342.USD","LU2362540622.SGD","BK4170","PPH","LU0868494617.USD","LU1057294990.SGD","LU0267386448.USD","LU0077335932.USD","RGTX","NVS","LU0823417737.USD","LU0058720904.USD","LU0444971666.USD","LU2324357040.USD","PHVS","BK4534","UNFI","LU2294711713.HKD","AMGN","SHAK","LU0187121727.USD","IE00B4R5TH58.HKD","BK4602","LU1571399168.USD","LU2543165471.USD","LU1983299246.USD","SEI","SRPT","WQTM","CNRG","LU2098885051.SGD","LU0823416689.USD","LU0345769128.USD","LU0985489474.SGD","LU2506951875.HKD","BK4548","LU2242652126.USD","LU0345769631.USD","LU1989772923.USD","BK4102","BK4168","VCLN","LU0823417653.USD","BK4124","BSX","LU2491050071.SGD","IE00B7SZL793.SGD","PBE","LU0950375773.USD","RGTZ","WATS","IONS","IE00BJT1NW94.SGD","LU0138981039.USD","IBBQ","LU0957808578.USD","LU1989764748.USD","BE","BHVN","ROIV","BEZ","LU1642822529.SGD","TBXU","SMOG","BK4131","LU2468319806.SGD","BK4504","BK4581","ICLN","LU1366192091.USD","LU1989764664.SGD","LU2242649171.HKD","LU2244417387.USD","OIH","LU1093756325.SGD","EGGY","BK4532","BK4541","BK4597","IE0009355771.USD","MEDX","BK4141","LU2362541513.USD","BK4566","LU1878469433.USD","LU0048584097.USD","LU0289739699.SGD","LU0353189680.USD","SG9999013999.USD","NTLA","BIB","LU2506951958.HKD","IE00B66KJ199.SGD","SRPU","BK4567","LU0011850046.USD","LU1718418525.SGD","LU1804176565.USD","SGXZ57979304.SGD","IE0031619046.USD","BK4535","BK4585","LU2087625088.SGD","LU0433182093.SGD","LU1548497426.USD","BK4007","ALV","BK4179","IBAT","LU0444973449.USD","LU2112291526.USD","IE00B2B36J28.USD","LU0320765992.SGD","PUL","LU0823414478.USD","LU0128526141.USD","SG9999001440.SGD","LU1861558580.USD","LU2357305700.SGD","DYN","LU1489326972.SGD","LU2264538146.SGD","IONQ","LU0251132253.USD","LU0070302665.USD","LU0208291251.USD","IOYY","LU1989772840.SGD","LU2249611893.SGD","FRNW","HYDR","LU0122379950.USD","LU1720051108.HKD","LU0528227936.USD","LU0109394709.USD","LU0432979614.USD","04332","IONC","LU2357125470.USD","LU0878866978.SGD","BK4082","LU1023059063.AUD","IE0009354923.USD","XES","LU0225283273.USD","GNMX","LU0320765489.SGD","LU1093756168.USD","BEC","USNG","LU0353189763.USD","IE00BJJMRZ35.SGD","SG9999001176.SGD","LU0154245756.USD","QTUP","ABM","BBH","LU1988902786.USD","LU2089984988.USD","BK4578","LU1815336760.USD","BK4533","IE00B19Z4B17.USD","LU1720051017.SGD","BK4588","LU1061106388.HKD","LU0476273544.USD","BK4139","VTWG","BK4591","RGTU","BK4209","LU0211331839.USD","IONX","LU0882574055.USD","LU1791710582.SGD","CQTM","RGTC","LU0889565916.HKD","SG9999001176.USD","BK4120","SIMS","ZAP","LU2506951792.HKD","SGML","LU0823414551.USD","CTEC","IE0002141913.USD","BK4121","LU0068578508.USD","LU2362541273.HKD","BK4599","P","BEG","IE00BFTCPJ56.SGD","BK4182","BK4505","BK4556","ILMN","BEX","LU2491049909.HKD","LU0029874061.USD","PTH","LU1989771016.USD","LU1791710400.SGD","IE0034235188.USD","CHRW","LU1861559042.SGD","RGTI","IBB","LU0266013472.USD","GNOM","LU1291159041.SGD","PJP","UPGR","LU0114720955.EUR","LU2242646821.SGD","RGYY","LU2491050154.USD","LU2265009873.SGD","LU2506952170.USD","LU1303367103.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178861295","title":"Movement Alert｜Roivant Sciences Ltd. Rises 14.2% in Regular Trading, Core Pipeline Mosliciguat Phase 2 Study Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1178861295","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178861295?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:30","pubTimestamp":1788874253,"startTime":"0","endTime":"0","summary":"On September 8, Roivant Sciences Ltd. rose 14.2% in regular trading, trading at $40.0/share, with turnover of $39.47 million. The rally was driven by the announcement that its Pulmovant unit's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Roivant Surges as Mosliciguat Hits Phase 2 Endpoints","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665891373","title":"Update: US Equity Futures Mostly Lower as Traders Assess Rising Oil, Canadian Retaliatory Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665891373","media":"MT Newswires Live","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665891373?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:55","pubTimestamp":1788872154,"startTime":"0","endTime":"0","summary":"(Updates with economic data, recent oil price movement, world markets' overview and corporate stock movements.)US equity futures were mostly lower pre-bell Tuesday, coming off a three-day weekend as t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03145","LU2247934214.USD","LU2028103732.USD","LU0353189763.USD","LU2089283258.USD","LU2092937221.SGD","DIPR","NATO","BK4533","BK4578","LU2089284900.SGD","LU2244417387.USD","AIQ","LU2112291526.USD","LU0208291251.USD","LU0882747503.HKD","BK4504","BK4141","LU0823434583.USD","BK4082","BK4532","CWI","BK4534","DBEU","TSMY","BK4591","LU1023057109.AUD","LU0878004406.USD","TSMZ","LU0094547139.USD","SG9999013999.USD","LU0077335932.USD","LU2360032135.SGD","LU2471134879.HKD","LU0072462343.USD","LU1548497426.USD","LU0082616367.USD","IE0002141913.USD","IE00B2B36J28.USD","LU0323591593.USD","LU0320765646.SGD","LU2471134523.USD","LU0823414551.USD","LU2506951792.HKD","SPTE","LU0098860793.USD","CGDG","IFLR","BSX","NVS","LU0084288322.USD","LU0320765489.SGD","LU2250418816.HKD","LU2023251221.USD","LU2125154778.USD","LU0114720955.EUR","LU0345770993.USD","ESIM","BK4007","MISL","LU2543165471.USD","LU0384037296.USD","BLOX","LU0187121727.USD","WDGF","ADVE","LU2360108059.USD","SG9999004220.SGD","LU1037948541.HKD","LU1868838027.USD","LU0889566641.SGD","LU1244550221.USD","FENI","THNR","LU1267930813.SGD","LU0965509283.SGD","LU1989764664.SGD","TWSC","LU0345770308.USD","LU1917777945.USD","ASMZ","LU1718418525.SGD","LU1282649067.USD","LU0792757196.USD","LU2237443382.USD","LU1061106388.HKD","LU0889565833.HKD","LU1316542783.SGD","PPA","LU2111349929.HKD","LU1093756325.SGD","LU2237443549.SGD","ASMU","IE0004091025.USD","BK4550","LU0122379950.USD","LU0175139822.USD","SG9999001176.USD","LU0965508806.USD","LU0266013472.USD","LU1929549753.HKD","LU1974910355.USD","STSM","IE00BKVL7J92.USD","PTH","ILOW","LU0882574055.USD","LU0432979614.USD","TEK","IE00BQXX3D17.EUR","LU1791710400.SGD","LU0070302665.USD","LU1211504680.USD","LU2106854487.HKD","CNEQ","LU0965509101.SGD","BK4526","BK4505","LU1803068979.SGD","FOWF","LU2054465674.USD","LU2265009873.SGD","LU2298321311.HKD","IE0004086264.USD","FDTX","LU1989772923.USD","MEDX","IE00B3M56506.USD","LU0719512351.SGD","PPH","LU2063271972.USD","BK4187","LU0823421416.USD","LU0158827781.USD","LU2506952170.USD","LMTL","LU0861579265.USD","LU2471134796.USD","LU0289960550.SGD","SGXZ99366536.SGD","BK4588","SMH","LU0642271901.SGD","ASMG","BK4512","LU0109392836.USD","NVOH","LU0345769631.USD","BK4564","LU2506951958.HKD","LU1037948897.HKD","LU1852331112.SGD","TINS","LU1244550577.SGD","LMT","BK4605","LU0359201885.HKD","IE0004445239.USD","EMC","IE00BJT1NW94.SGD","LU2506951875.HKD","LU2860962120.EUR","LU0267386448.USD","IE00B5TLWC47.USD","LU0488056044.USD","BK4548","LU2023250504.SGD","TTEQ","TSM","LU1093756168.USD","IE0009355771.USD","LU0211327993.USD","LU1868837722.USD","LU2271345857.HKD","UMMA","WUGI","LU0541501648.USD","LU0541502299.USD","LU0823417653.USD","LU2491050154.USD","KNOW","IEFA","ASML","LU0878005551.USD","LU0225283273.USD","IE00B4R5TH58.HKD","LU2211815571.USD","LU1989772840.SGD","LU1734074674.USD","LU1162221912.USD","LU0823414478.USD","TSMG","HBMX","BK4527","BK4585","BK4147","LU2324357040.USD","LU0345769128.USD","LU2211814178.USD","DBEF","NVOC","LU2242649171.HKD","SHLD","ROIV","LU0310799852.SGD","LU2458330169.SGD","BK4612","LU0138981039.USD","LU0689626769.HKD","CGIC","LU1791710582.SGD","LU0823434740.USD","CGNG","IE00BQXX3C00.GBP","SPWO","IE00BKPKM429.USD","LU0316494557.USD","SGXZ51526630.SGD","EMM","LU2750360997.AUD","IE00BFTCPJ56.SGD","LU0353189680.USD","LU1989764748.USD","LU0143863198.USD","LU0528227936.USD","LU2362541273.HKD","LU0359202008.SGD","SGXZ81514606.USD","PQNT","IE00BZ1G4Q59.USD","IE00BFXG0V08.USD","BK4516","LU1934455863.HKD","LU1720051108.HKD","LU0359201612.USD","LU2663582299.SGD","LU0823421333.USD","TSMU","LU2237443622.USD","LU1057294990.SGD","IE00BYQQ9H92.USD","LU2133065610.SGD","LU1153585028.USD","LU2458330243.SGD","LU2087625088.SGD","LU0011850046.USD","LU1323610961.USD","LU2471134952.CNY","OZEM","LU1366192091.USD","LU1623119135.USD","CHPX","LU0198837287.USD","LU0143863784.USD","LU0348723411.USD","LU1934455277.USD","LU0097036916.USD","LU0345774391.USD","LU1508157978.USD","LU2360106780.USD","LU2750360641.GBP","NVO","ASIA","LU0154236417.USD","LU0211331839.USD","LU1983299246.USD","CGGO","IE00BQXX3F31.USD","LU1989771016.USD","LU2294711713.HKD","BAI","LU1720051017.SGD","LU1804176565.USD","TSMX","BK4581","SGXZ57979304.SGD","EPAI","LU1934455194.USD","LU2237443978.SGD","IDEF","LU2491050071.SGD","SG9999001176.SGD","BK4139","LU1712237335.SGD","LU0056508442.USD","AVXC","IE00BJJMRZ35.SGD","LU0158827948.USD","LU0823416689.USD","03165","LU1291159041.SGD","LU0823417737.USD","LU0251132253.USD","CORO","LMTS","FFGX","LU0572939691.SGD","LU0264606111.USD","LU1282649810.SGD","IE00BD6J9T35.USD","GSID","LU2506952097.USD","LU2249611893.SGD","LU2362540622.SGD","NVOX","LU0345774631.USD","BK4602","BK4599","LU0950375773.USD","AVSE","EFA","LU0211328371.USD","LU0965509010.AUD","BK4604","ASMH","BK4554","AVEM","LU1244550494.USD","LU0572940350.SGD","LU2362541513.USD","LU1267930490.SGD","LU0238689110.USD","BK4543","LU1023059063.AUD","LU2357305700.SGD","LU0124676726.USD","LU0048584097.USD","SG9999000418.SGD","LU2125154935.USD","LU2491049909.HKD","LU1868837565.USD","MEMX","IE00BHPRN162.USD","LU2357125470.USD","IE00BZ199S13.USD","BK4503","LU1048588211.SGD","LU2041044095.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322709","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322709","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322709?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:15","pubTimestamp":1788866115,"startTime":"0","endTime":"0","summary":"CEA Industries  shares were up over 63% in Tuesday's premarket activity following a 6.1% rise in the prior trading session on Thursday.GMEX Robotics  stock was 23% higher, swinging from the 5.5% loss in the earlier sessionRoivant Sciences  shares were up 23% after the company said its Pulmovant unit's phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease, or PH-ILD, met its primary and secondary endpoints.Upstream Bio  stock was 11% higher after the company said it presented phase 2 clinical trial results for its lead severe asthma treatment candidate, verekitug, at the European Respiratory Society Congress in Barcelona.Eightco  shares were up 8% following a 6.8% fall in the prior session.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4220","ORBS","BK4007","BNC","PTH","BK4200","ROIV","BK4086","UPB","GMEX","BK4139","BK4136"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324029","title":"Roivant Sciences Shares Rise on Positive Mid-Stage Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324029","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324029?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:51","pubTimestamp":1788864660,"startTime":"0","endTime":"0","summary":"Shares of Roivant Sciences climbed after the company disclosed what it called positive results from a mid-stage trial evaluating its treatment for some instances of pulmonary hypertension, or high blo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PTH","BK4139","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665248463","title":"Roivant Sciences Jumps After Lung Disease Drug Meets Main Goal in Mid-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665248463","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665248463?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:25","pubTimestamp":1788863137,"startTime":"0","endTime":"0","summary":"BUZZ-Roivant Sciences jumps after lung disease drug meets main goal in mid-stage study** Shares of Roivant SciencesROIV.Orise 21.7% to $42.50 premarket** The drug developer's Pulmovant unit says its experimental inhaled therapy, mosliciguat, met the primary goal in a mid-stage study in patients with pulmonary hypertension associated with interstitial lung disease** It is a condition where high blood pressure develops in the lung arteries due to scarring or inflammation in the lungs** The study showed a 56.3% placebo-adjusted reduction in resistance in the lungs' blood vessels at 16 weeks** The drug also met secondary goals: improving six-minute walk distance by 35.2 meters vs placebo; reducing levels of NT-proBNP, a biomarker of cardiac strain, by 53.2% at week 16** Cough, a common side effect associated with inhaled prostacyclin therapies, was reported in 12.1% of patients receiving mosliciguat vs 18.2% on placebo** ROIV says it has already initiated the late-stage study of moslicigua","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500PT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4139","ROIV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://roivant.com;investor.roivant.com","stockEarnings":[{"period":"1week","weight":-0.0324},{"period":"1month","weight":0.0529},{"period":"3month","weight":0.1238},{"period":"6month","weight":0.3974},{"period":"1year","weight":1.5582},{"period":"ytd","weight":0.7613}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0547},{"period":"6month","weight":0.1989},{"period":"1year","weight":0.1598},{"period":"ytd","weight":0.1341}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.071559},{"month":2,"riseRate":0.333333,"avgChangeRate":0.052607},{"month":3,"riseRate":0,"avgChangeRate":-0.087601},{"month":4,"riseRate":0.833333,"avgChangeRate":0.021573},{"month":5,"riseRate":0.5,"avgChangeRate":0.035469},{"month":6,"riseRate":0.833333,"avgChangeRate":0.042574},{"month":7,"riseRate":0.666667,"avgChangeRate":0.026843},{"month":8,"riseRate":0.666667,"avgChangeRate":0.010529},{"month":9,"riseRate":0.5,"avgChangeRate":0.028143},{"month":10,"riseRate":0.6,"avgChangeRate":0.101456},{"month":11,"riseRate":0.8,"avgChangeRate":0.02515},{"month":12,"riseRate":0.8,"avgChangeRate":0.23185}],"exchange":"NASDAQ","name":"Roivant Sciences Ltd.","nameEN":"Roivant Sciences Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Roivant Sciences Ltd.(ROIV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Roivant Sciences Ltd.(ROIV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Roivant Sciences Ltd.,ROIV,Roivant Sciences Ltd.股票,Roivant Sciences Ltd.股票老虎,Roivant Sciences Ltd.股票老虎国际,Roivant Sciences Ltd.行情,Roivant Sciences Ltd.股票行情,Roivant Sciences Ltd.股价,Roivant Sciences Ltd.股市,Roivant Sciences Ltd.股票价格,Roivant Sciences Ltd.股票交易,Roivant Sciences Ltd.股票购买,Roivant Sciences Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Roivant Sciences Ltd.(ROIV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Roivant Sciences Ltd.(ROIV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}